GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Cash Flow for Lease Financing

Abera Bioscience AB (XSAT:ABERA) Cash Flow for Lease Financing : kr0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Abera Bioscience AB Cash Flow for Lease Financing?

Abera Bioscience AB's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was kr0.00 Mil. Abera Bioscience AB's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Dec. 2024 ), Abera Bioscience AB's Cash Flow for Lease Financing remained the same in Mar. 2025 (kr0.00 Mil).

Abera Bioscience AB Cash Flow for Lease Financing Historical Data

The historical data trend for Abera Bioscience AB's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abera Bioscience AB Cash Flow for Lease Financing Chart

Abera Bioscience AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

Abera Bioscience AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Abera Bioscience AB Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abera Bioscience AB Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Abera Bioscience AB's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Abera Bioscience AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Cash Flow for Lease Financing
Comparable Companies
OSTO:BIOSGN XSAT:BIOWKS OSTO:KAN XSAT:DEX OSTO:ALZ OSTO:NICA OSTO:PILA NGM:GTAB B OSTO:SPAGO OSTO:NXTCL VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Box 26029, Uppsala, SWE, 750 26
Website
https://www.aberabio.com
Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.

Abera Bioscience AB Headlines

No Headlines